Skip to end of metadata
Go to start of metadata

1a. Project Name

Vital Signs PSS

1b. Project ID


1c. Is Your Project an Investigative Project (aka PSS-Lite)?


1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?


1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Orders & Observations

2b. Co-Sponsor WG

Clinical Information Modeling Initiative

2c. Co-Sponsor Level of Involvement

Other Involvement. Specify details in text box below

2c. Co-Sponsor Involvement

Creation of logical models, FHIR profiles, and IG

2d. Project Facilitator

Stan Huff

2e. Other Interested Parties (and roles)

2f. Modeling Facilitator

Nathan Davis

2g. Publishing Facilitator

Nathan Davis

2h. Vocabulary Facilitator

Susan Matney

2i. Domain Expert Representative

Susan Matney

2j. Business Requirements Analyst

2k. Conformance Facilitator

Richard Esmond

2l. Other Facilitators

Galen Mulrooney, Jay Lyle

2m. Implementers

Intermountain Healthcare
University of Utah
American Medical Association

3a. Project Scope

To create the terminology content, logical models, FHIR profiles and implementation guides for all of vital signs including all qualifying observations (patient position, body location, device, method, etc.) and coded value sets, building on the FHIR Vital Signs profile currently in place.

This FHIR implementation guide will use the US Core profiles. If this FHIR implementation guide is unable to use a US Core profile we will request approval from US Realm SC, and provide the US Realm approved rationale for deviation in the implementation guide where applicable.


3b. Project Need

Vital signs are collected on nearly every patient encounter. Oftentimes, the clinician needs to know the patient position, device, body location or method the measures were taken.

Blood pressure as a component of vital signs also plays a key role in national efforts to control hypertension in the U.S.. This project is collaborating with the AMA in supporting the Target BP program which is focused on helping health care organizations, at no cost, improve BP control rates through an evidence-based quality improvement program and recognizes organizations committed to improving BP control, measure blood pressure accurately and enable patient self-measurement (SMBP). SMBP can also help providers better diagnose high BP and effectively manage patients. More information can be found at

The goal for this project identify the additional qualifiers, and value sets and add them encode them within the FHIR profile.

3c. Security Risk


3d. External Drivers

3e. Objectives/Deliverables and Target Dates

1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Develop the FHIR profiles (complete)
4. QA the FHIR profile with CIMI (complete)
5. Develop the IG. (first draft complete, second draft cjomplete)
6. Connectathon (May HL7 meeting)
7. Ballot Sept 2020

3f. Common Names / Keywords / Aliases:

Vital Signs, Vital Signs profiles, Vital Signs IG

3g. Lineage

3h. Project Dependencies

3i. HL7-Managed Project Document Repository URL:

3j. Backwards Compatibility


3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?


3l. Reason for not using current V3 data types?

3m. External Vocabularies


3n. List of Vocabularies


3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

FHIR Extensions, FHIR Implementation Guide, FHIR Profiles, FHIR Resources, Logical Model

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

STU3, R4

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Implementation Guide (IG) will be created/modified

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?


5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

5b. Project Ballot Type

STU to Normative

5c. Additional Ballot Info

Success criteria: Development of the vital signs IG that supports US Core as well as SMBP use cases that are provided by the AMA Target BP program.

5d. Joint Copyright


5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.


6a. External Project Collaboration

Intermountain Healthcare
American Medical Association

6b. Content Already Developed


6c. Content externally developed?


6d. List Developers of Externally Developed Content

Intermountain Healthcare, HSPC

6e. Is this a hosted (externally funded) project?


6f. Stakeholders

Clinical and Public Health Laboratories, Quality Reporting Agencies, Standards Development Organizations (SDOs)

6f. Other Stakeholders

6g. Vendors

EHR, PHR, Health Care IT, Clinical Decision Support Systems, HIS

6g. Other Vendors

6h. Providers

Clinical and Public Health Laboratories, Emergency Services, Healthcare Institutions (hospitals, long term care, home care, mental health)

6h. Other Providers

6i. Realm

U.S. Realm Specific

7d. US Realm Approval Date

Jan 21, 2020

7a. Management Group(s) to Review PSS


7b. Sponsoring WG Approval Date

May 23, 2019

7c. Co-Sponsor Approval Date

May 23, 2019

7c. Co-Sponsor 2 Approval Date

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

Jan 08, 2020

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

Mar 13, 2020

7j. TSC Approval Date

Mar 23, 2020

 Show Changes